Publications by authors named "J Vogler"

In the United States, requirements for flood insurance, development restrictions, and federal buyout program eligibility rely on regulatory designation of hazardous zones, i.e., inside or outside the 100-year floodplain.

View Article and Find Full Text PDF

Background: Ablation strategies for patients with symptomatic atrial fibrillation and isolated pulmonary veins vary and their effects on arrhythmia recurrence remain unclear. A prospective randomized German multicenter trial sought to compare 2 ablation strategies in this patient cohort.

Methods: Patients with atrial fibrillation despite durable pulmonary vein isolation were randomly assigned at 7 centers to undergo low-voltage area ablation using 3-dimensional mapping and irrigated radiofrequency current ablation (group A) or empirical left atrial appendage isolation (LAAI) using the cryoballoon followed by staged interventional left atrial appendage closure (group B).

View Article and Find Full Text PDF

Background: The Manufacturer and User Facility Device Experience (MAUDE) database houses medical device reports of adverse events involving medical devices marketed in the United States submitted to the U.S. Food and Drug Administration (FDA) by mandatory and voluntary reporters.

View Article and Find Full Text PDF

Inflammation is a complex physiological process that plays a pivotal role in many if not all pathological conditions, including infectious as well as inflammatory diseases, like periodontitis and autoimmune disorders. Inflammatory response to periodontal biofilms and tissue destruction in periodontitis is associated with the release of inflammatory mediators. Chronic inflammation can promote the development of cancer.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to evaluate the performance and safety of subcutaneous-implantable cardioverter defibrillator (S-ICD) technology in athletes compared to nonathletes, focusing on device-related complications and shock occurrences.
  • Athletes made up 10.2% of the 1493 patients studied and showed higher incidences of certain heart conditions, with a tendency to experience appropriate shocks more frequently during exercise, although this was not statistically significant after adjusting for other factors.
  • Overall, S-ICDs appear to be a safe option for athletes, as there was no significant difference in overall complications or inappropriate shocks between the two groups, though athletes had a higher risk of myopotential oversensing and lead infections shortly after implant.
View Article and Find Full Text PDF